No evidence of carbapenemase-producing Enterobacteriaceae in stool samples of 1,544 asylum seekers arriving in Rhineland-Palatinate, Germany, April 2016 to March, 2017

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
Lutz EhlkesJan Walter

Abstract

Since 2015, increased migration from Asia and Africa to Europe has raised public health concerns about potential importation of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE), specifically those producing carbapenemases (C-PE), into European hospitals. To inform infection control practices about ESBL-PE prevalence in asylum seekers and to investigate whether C-PE prevalence exceeds that in the German population. Cross-sectional study from April 2016-March 2017. Routinely collected stool samples from asylum seekers were tested for antibiotic resistant Enterobacteriaceae. Country/region of origin and demographic characteristics were explored as risk factors for faecal colonisation. Of 1,544 individuals, 294 tested positive for ESBL-PE colonisation (19.0%; 95% confidence intervals (CI): 17.0-21.0). Asylum seekers originating from Afghanistan/Pakistan/Iran had a prevalence of 29.3% (95% CI: 25.6-33.2), from Syria 20.4% (95% CI: 16.1-25.2) and from Eritrea/Somalia 11.9% (95% CI: 8.7-15.7). CTX-M-15 (79%) and CTX-M-27 (10%) were the most common ESBL determinants. Highest ESBL-PE prevalences were observed in boys under 10 years and women aged 20-39 years (interaction: p = 0.03). No individuals tested positive for...Continue Reading

References

Sep 30, 2000·Applied and Environmental Microbiology·O ClermontE Bingen
Apr 25, 2006·FEMS Microbiology Letters·Jane F TurtonTyrone L Pitt
Sep 7, 2006·Antimicrobial Agents and Chemotherapy·Chi Hye ParkDavid C Hooper
Oct 1, 2009·Emerging Infectious Diseases·Yvonne PfeiferWolfgang Rabsch
Jan 12, 2010·International Journal of Antimicrobial Agents·Gisele Peirano, Johann D D Pitout
Nov 18, 2010·The Journal of Antimicrobial Chemotherapy·Benjamin A RogersDavid L Paterson
Jun 23, 2011·The Journal of Antimicrobial Chemotherapy·Yvonne PfeiferPaul G Higgins
Jun 9, 2012·The Journal of Antimicrobial Chemotherapy·Akke K van der Bij, Johann D D Pitout
Dec 4, 2013·Antimicrobial Agents and Chemotherapy·Giuseppe ValenzaChristiane Höller
Dec 18, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E TacconelliUNKNOWN European Society of Clinical Microbiology
Jul 2, 2014·Clinical Microbiology Reviews·Marie-Hélène Nicolas-ChanoineJean-Yves Madec
Jan 24, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anu KanteleJuha Kirveskari
Apr 24, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Etienne RuppéSophie Matheron
Nov 26, 2015·Lancet·Alison H HolmesLaura J V Piddock
Jan 23, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Claudia ReinheimerChristian Brandt
Feb 4, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Ursel HeudorfChristian Zinn
May 5, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Styliani KaranikaEleftherios Mylonakis
Nov 5, 2016·American Journal of Infection Control·Anaelís C CamposJorge J V Teixeira
Jun 19, 2016·The Journal of Antimicrobial Chemotherapy·A HamprechtUNKNOWN DZIF-ATHOS Study Group
Jul 16, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Basil Britto XavierSurbhi Malhotra-Kumar
Oct 22, 2016·Emerging Infectious Diseases·Yasufumi MatsumuraSatoshi Ichiyama
Apr 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah Tschudin-SutterStephan Harbarth
Apr 26, 2017·PloS One·Sofanne J RavensbergenAlewijn Ott
May 26, 2017·The Journal of Antimicrobial Chemotherapy·Edward R BevanPeter M Hawkey
Oct 19, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Benedikt LohrKlaus-Peter Hunfeld
May 24, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Lutz EhlkesPhilipp Zanger

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

EpiData
Vitek
Stata

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.